New Launch25 Mar 2025, 01:38 am
IOL Chemicals & Pharmaceuticals Ltd. Commences New Paracetamol Unit & Expands Clopidogrel Manufacturing Facility
AI Summary
IOL Chemicals & Pharmaceuticals Ltd. has started a new state-of-the-art unit for Paracetamol production (Unit-11) with an installed capacity of 10,800 MTPA. The new unit is supported by backward integration with in-house production of key intermediates, Para Amino Phenol (PAP) and Acetic Anhydride. Additionally, the company has expanded the installed capacity of Unit 5 for manufacturing Clopidogrel Bisulphate from 180 MTPA to 240 MTPA. Both expansions were completed on 24th March 2025. The total capital expenditure for the Clopidogrel Bisulphate expansion was Rs. 7.87 crore, funded through internal accruals.
Key Highlights
- Commencement of new state-of-the-art Unit-11 for Paracetamol production with a capacity of 10,800 MTPA.
- Backward integration with in-house production of key intermediates, Para Amino Phenol (PAP) and Acetic Anhydride for Paracetamol manufacturing.
- Expansion of Clopidogrel Bisulphate manufacturing facility (Unit-5) from 180 MTPA to 240 MTPA.
- Total capital expenditure of Rs. 7.87 crore for the Clopidogrel Bisulphate expansion.
- Expansions completed on 24th March 2025, funded through internal accruals.